Advanced Research of Ionizing Radiation in Cancers
A special issue of Current Issues in Molecular Biology (ISSN 1467-3045). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: closed (31 May 2024) | Viewed by 4341
Special Issue Editors
Interests: molecular imaging; internal radiotherapy; radiopharmacology
Special Issues, Collections and Topics in MDPI journals
Interests: radiopharmaceuticals; radioactive tracers; nuclear medicine radiolabeling; new PET imaging radionuclides
Special Issues, Collections and Topics in MDPI journals
Interests: thyroid; PET imaging; oncology diagnosis and therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Radiation exposure of individuals has been increasing due to increased radiation use. The carcinogenic effect of ionizing radiation is a delayed effect, the probability of occurrence depends on the radiation dose. Cancers associated with high dose exposure include leukemia, breast cancer, bladder cancer, colon cancer, liver cancer, lung cancer, esophagus cancer, ovarian cancer, multiple myeloma and stomach cancer. The cancer risk of low-dose radiation compared with high-dose ionizing radiation has become an important part of radiation protection and has raised public and societal concerns about safety related to various issues. For example, in medicine for diagnostic imaging and therapeutic procedures, in industrial applications including nuclear power plants, and in academia for education and scientific research. Cancer risk assessment for more common or long-term radiation exposure is still under debate, and its uncertainties make it a murky field. I am pleased to invite you to participate to this Special Issue “Advanced Research of Ionizing Radiation in Cancers”. Research papers, up-to-date review articles, and comments about molecular research are all welcome.
Dr. Carlo Aprile
Dr. Lorenzo Lodola
Dr. Onelio Geatti
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Issues in Molecular Biology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- radiation induced cancer
- radiobiology
- space radiobiology
- heavy ions carcinogenesis
- LinearNonTreshold